Structure-based discovery of a novel nuclear receptor PPARγ inhibitor: Implications for obesity and metabolic disease intervention

15 May 2026
0

Structure-based discovery of a novel nuclear receptor PPARγ inhibitor: Implications for obesity and metabolic disease intervention

Tachachartvanich P, Sangsuwan R, Ngernpisutsilp N, Prawat H, Kaweetripob W, Ruchirawat M, Ruchirawat S

Biomed Pharmacother. 2025;192:118615.

Tags

Share this

Related Posts

Overexpression of Stenotrophomonas maltophilia major facilitator superfamily protein MfsA increases resistance to fluoroquinolone antibiotics. Vattanaviboon P, Dulyayangkul P, Mongkolsuk S, Charoenlap N. J Antimicrob Chemother. 2018 Feb 14. doi: 10.1093/jac/dky024. [Epub ahead of print]
Sureram, S.; Wiyakrutta, S.; Ngamrojanavanich, N.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Depsidones, Aromatase Inhibitors and Radical Scavenging Agents from the Marine-Derived Fungus Aspergillus unguis CRI282-03. Planta Med. 2012 ,78(6), 582-588

Recent Posts